G PROTEINS INHIBITION RESCUES CONTRACTILE RESPONSE--BETA2 ADRENERGIC STIMULATION
G 蛋白抑制可挽救收缩反应——β2 肾上腺素刺激
基本信息
- 批准号:6160502
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
SUMMARY OF WORK
Previous studies showing that beta-adrenergic receptor (betaAR)
stimulation cannot increase cardiac contractility in transgenic mice
overexpressing the human beta2ARs (TG4) were interpreted to indicate that
the baseline cardiac contractility of TG4 mice was already enhanced to the
maximal level, due to a greater number of spontaneous active beta2ARs (R*)
in the absence of agonist. To test this hypothesis and the underlying
mechanisms, we investigated effects of beta2AR stimulation on contraction
and intracellular Ca2+ transient in TG4 ventricular myocytes and adenylyl
cyclase activity in TG4 cardiac membranes. We also examined possible
involvement of inhibitory G proteins and betaAR kinase1 (betaARK1) in the
loss of TG4 cardiac betaAR response. Baseline contractility of TG4
ventricular myocytes was increased by three-fold relative to wild type
controls. Beta2AR stimulation by zinterol had no effect on either the
contractility or adenylyl cyclase activity in TG4 mice, whereas an
adenylyl cyclase activator, forskolin, markedly increased the contraction
amplitude, suggesting that TG4 cardiac beta2ARs might be desensitized or
uncoupled from down-stream signaling cascades. BetaARK1 activity was not
significantly altered in TG4 hearts. However, pertussis toxin (PTX)
treatment fully rescued the intracellular Ca2+ transient, contractile and
adenylyl cyclase responses to beta2AR stimulation, indicating
PTX-sensitive G proteins are responsible for the unresponsiveness of
cardiac beta2ARs in TG4 mice. This was further confirmed by the increased
incorporation of a photoreactive GTP analog, [alpha-32P]GTP azidoanilide,
into alpha- subunits of Gi2 and Gi3 following beta2AR stimulation by
zinterol or isoproterenol plus a1betaAR blocker, CGP 20712A. The beta2AR
stimulatory effect on Gi protein was abolished by a selective beta2AR
blocker ICI 118,551 or by PTX treatment. In contrast, a beta1AR agonist,
norepinephrine (10-6 M), can not enhance the incorporation of Gi proteins.
Thus, we conclude that the loss of cardiac contractile response to beta2AR
stimulation during chronic spontaneous beta2AR activation is not due to
the enhanced baseline contractility or to betaARK1-mediated receptor
desensitization, but due to an activation of the beta2AR-coupled
PTX-sensitive G proteins, Gi2 and Gi3.
工作概要
先前的研究表明,β-肾上腺素能受体(β AR)
刺激不能增加转基因小鼠的心肌收缩力
过表达人β 2 AR(TG 4)被解释为表明,
TG 4小鼠的基线心肌收缩力已经增强到
最大水平,由于自发活性β 2 AR数量较多(R*)
在没有激动剂的情况下。为了验证这一假设和潜在的
机制,我们研究了β 2 AR刺激对收缩的影响,
TG 4心室肌细胞内Ca 2+瞬变和腺苷酸
TG 4心脏膜中的环化酶活性。 我们还研究了
抑制性G蛋白和β AR激酶1(β ARK 1)参与了
TG 4心脏β AR反应丧失。TG 4的基线收缩力
心室肌细胞相对于野生型增加了三倍
对照锌特罗刺激β 2 AR对两种细胞均无影响。
收缩力或腺苷酸环化酶活性,而
腺苷酸环化酶激活剂,毛喉素,显着增加收缩
这表明TG 4心脏β 2 AR可能是脱敏的,
与下游信号级联解耦。BetaARK 1活性不是
在TG 4心脏中显著改变。 百日咳毒素(PTX)
治疗完全挽救了细胞内Ca 2+瞬变,收缩和
腺苷酸环化酶对β 2 AR刺激的反应,表明
PTX敏感的G蛋白是导致
TG 4小鼠的心脏β 2 AR。这一点得到了进一步证实,
掺入光反应性GTP类似物,[α-32 P]GTP叠氮酰苯胺,
在β 2 AR刺激后,
锌特罗或异丙肾上腺素加α 1 β AR阻滞剂,CGP 20712 A。 beta2AR
对Gi蛋白的刺激作用被选择性β 2 AR所消除
阻断剂ICI 118,551或PTX治疗。相反,β 1 AR激动剂,
去甲肾上腺素(10-6 M)不能增强Gi蛋白的掺入。
因此,我们的结论是,心脏收缩反应的损失,β 2 AR
慢性自发β 2 AR激活期间的刺激不是由于
增强的基线收缩力或β ARK 1介导的受体
脱敏,但由于激活β 2AR-偶联
PTX敏感性G蛋白,Gi 2和Gi 3。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R P XIAO其他文献
R P XIAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R P XIAO', 18)}}的其他基金
CALMODULIN-DEPENDENT PROTEIN KINASE II IN HEART CALCIUM CHANNEL REGULATION
钙调蛋白依赖性蛋白激酶 II 在心脏钙通道调节中的作用
- 批准号:
3767884 - 财政年份:
- 资助金额:
-- - 项目类别:
CONTRASTING CELLULAR EFFECTS OF BETA1 AND BETA2 ADRENERGIC RECEPTOR STIMULATION
对比 β1 和 β2 肾上腺素能受体刺激的细胞效应
- 批准号:
3802249 - 财政年份:
- 资助金额:
-- - 项目类别:
COMPARISON BETA2 VS BETA1 ADRENOCEPTOR STIMULATION IN RAT CARDIOCYTE STIMULATION
大鼠心肌细胞刺激中BETA2 与BETA1 肾上腺素受体刺激的比较
- 批准号:
3767797 - 财政年份:
- 资助金额:
-- - 项目类别:
DIRECT COUPLING OF B2 ADRENERGIC RECEPTOR TO INHIBITORY G PROTEINS IN MYOCYTES
B2 肾上腺素受体与心肌细胞中抑制性 G 蛋白的直接偶联
- 批准号:
2565771 - 财政年份:
- 资助金额:
-- - 项目类别:
CALMODULIN-DEPENDENT PROTEIN KINASE II IN HEART CALCIUM CHANNEL REGULATION
钙调蛋白依赖性蛋白激酶 II 在心脏钙通道调节中的作用
- 批准号:
3745559 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF CONTRACTILE DEFICIT OF RAT HEART CELLS TO NOREPINEPHRINE WITH AGING
衰老过程中大鼠心脏细胞对去甲肾上腺素收缩性缺陷的机制
- 批准号:
3789878 - 财政年份:
- 资助金额:
-- - 项目类别:
COMPARISON BETA2 VS BETA1 ADRENOCEPTOR STIMULATION IN RAT CARDIOCYTE STIMULATION
大鼠心肌细胞刺激中BETA2 与BETA1 肾上腺素受体刺激的比较
- 批准号:
3745465 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISMS OF B1 AND B2 ADRENERGIC ACTIONS IN CANINE HEART CELLS
B1 和 B2 肾上腺素在犬心脏细胞中的作用机制
- 批准号:
5200364 - 财政年份:
- 资助金额:
-- - 项目类别:
COMPARISON BETA2 VS BETA1 ADRENOCEPTOR STIMULATION IN RAT CARDIOCYTE STIMULATION
大鼠心肌细胞刺激中BETA2 与BETA1 肾上腺素受体刺激的比较
- 批准号:
3789799 - 财政年份:
- 资助金额:
-- - 项目类别:
INTERACTION OF SIGMA OPIOID AND BETA ADRENERGIC RECEPTORS IN CARDIAC MYOCYTES
心肌细胞中西格玛阿片类药物和β肾上腺素能受体的相互作用
- 批准号:
3789800 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
- 批准号:
451966 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10455587 - 财政年份:2020
- 资助金额:
-- - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10261394 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
- 批准号:
20K08498 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
- 批准号:
10380126 - 财政年份:2020
- 资助金额:
-- - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10662279 - 财政年份:2020
- 资助金额:
-- - 项目类别: